40 results on '"Ahmadi, Michael"'
Search Results
2. Florbetapir PET Uptake in White Matter in Aging and Alzheimer’s Disease
3. Posterior cingulate cortex microRNA alterations in cognitive resilience, mild cognitive impairment, and Alzheimer’s disease
4. Higher systolic and diastolic blood pressures in recently postmenopausal women are associated with greater WMH more than a decade later in the KEEPS Continuation
5. Higher systolic and diastolic blood pressures in recently postmenopausal women are associated with greater WMH more than a decade later in the KEEPS Continuation
6. Reproductive health data and its relationship to baseline brain imaging and cognitive measurements in cognitively unimpaired female PSEN1 E280A mutation carriers and non‐carriers from the API ADAD Trial
7. Head‐to‐Head Comparison of Four Plasma Phospho‐Tau Immunoassays in the Neuropathological Diagnosis of Alzheimer’s Disease
8. White Matter Hyperintensity and PET‐Based Amyloid Load Correlations: A Meta‐Analysis
9. Plasma neurofilament light chain in cognitively unimpaired late middle‐aged & older adult APOE ε4 homozygotes, heterozygotes, & non‐carriers from the Arizona APOE Cohort
10. Neuropathological Validation of the Alzheimer’s Questionnaire
11. Meta‐Analysis of Animal Fluency Performance in Amnestic Mild Cognitive Impairment and Cognitively Unimpaired Older Adults.
12. CSF amyloid‐beta, tau, and neurodegenerative and inflammatory biomarkers in cognitively unimpaired late middle‐aged and older adult APOE ε4 homozygotes, heterozygotes, and non‐carriers from the Arizona APOE Cohort
13. Ultrasound‐assisted lumbar puncture in Alzheimer's disease and related disorders research: A pilot study
14. Higher systolic and diastolic blood pressures are associated with loss of white matter integrity in postmenopausal women of the KEEPS Continuation Study
15. A novel longitudinal approach in individual subjects to investigate the movement of tau over time using graph theory in clinical and preclinical stages of Alzheimer’s disease
16. P4-374: DEPRESSIVE AND ANXIETY SYMPTOM VARIABILITY ATTENUATES MEMORY AND EXECUTIVE FUNCTION MEASURE DECLINE ESTIMATES IN COGNITIVELY UNIMPAIRED OLDER ADULTS
17. P3-334: IMPACT OF CEREBRAL ISCHEMIA SCORES, FIBRILLAR AMYLOID-B BURDEN AND AGE ON WHITE MATTER HYPERINTENSITY VOLUMES IN COGNITIVELY UNIMPAIRED OLDER ADULT APOE4 CARRIERS AND NON-CARRIERS
18. F4-04-02: AGE-RELATED CHANGES IN BASELINE COGNITIVE MEASURES IN UNIMPAIRED PSEN1 E280A MUTATION CARRIERS AND NON-CARRIERS IN THE API AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE COLOMBIA TRIAL
19. P4-611: DOMAIN-SPECIFIC SUBJECTIVE MEMORY COMPLAINTS ARE ASSOCIATED WITH MONTREAL COGNITIVE ASSESSMENT PERFORMANCE IN COGNITIVELY UNIMPAIRED OLDER ADULTS
20. P1-418: INDIVIDUAL-BASED NETWORK ANALYSIS: A NOVEL APPROACH TO INVESTIGATE THE PATHOLOGICAL SPREAD OF PHF TAU USING GRAPH THEORY IN CLINICAL AND PRECLINICAL STAGES OF ALZHEIMER'S DISEASE
21. P4-308: AN ADAPTIVE SAMPLING FRAMEWORK FOR PARTIAL VOLUME CORRECTION OF β-AMYLOID PET
22. IC-P-173: INDIVIDUAL-BASED NETWORK ANALYSIS: A NOVEL APPROACH TO INVESTIGATE THE PATHOLOGICAL SPREAD OF PHF TAU USING GRAPH THEORY IN CLINICAL AND PRECLINICAL STAGES OF ALZHEIMER'S DISEASE
23. P1-480: APOE-DEPENDENT VERBAL LEARNING EFFECTS IN COGNITIVELY UNIMPAIRED OLDER ADULTS
24. P2-360: COVARYING SPATIAL PATTERNS OF TAU DEPOSITION AND GRAY MATTER ATROPHY UNEARTHED BY THE INFORMED MULTIMODAL PARTIAL LEAST SQUARES (MMPLS) IN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE: FINDINGS FROM THE COLBOS PROJECT
25. P2-430: RELATIONSHIPS BETWEEN LONGITUDINAL RATES OF LEARNING AND MEMORY DECLINE AND DIFFERENT FORMS OF CEREBROVASCULAR PATHOLOGY IN COGNITIVELY UNIMPAIRED BRAIN DONORS
26. IC-P-058: COVARYING SPATIAL PATTERNS OF TAU DEPOSITION AND GRAY MATTER ATROPHY UNEARTHED BY THE INFORMED MULTIMODAL PARTIAL LEAST SQUARES (MMPLS) IN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE: FINDINGS FROM THE COLBOS PROJECT
27. O2‐03‐04: CEREBRAL AMYLOID ANGIOPATHY CORRELATES WITH COGNITIVE DECLINE IN PRECLINICAL AD
28. [P2-434]: INTELLECTUAL FUNCTION VERSUS YEARS OF EDUCATION AS COGNITIVE RESERVE PROXIES: INTERACTION WITH ALZHEIMER's DISEASE NEUROPATHOLOGY AND IMPACT ON EPISODIC MEMORY AND EXECUTIVE FUNCTION
29. P1-341: Neurofibrillary Tangle Predominant Dementia: Clinical and Pathological Description in a Case Series
30. Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia
31. O1-11-04: CARDIOVASCULAR RISK FACTORS AND THEIR INTERACTIONS AMONG CLINICALLY DEFINED NEURODEGENERATIVE DISEASES
32. P1–358: Florbetapir PET, FDG‐PET and MRI in people with Down syndrome with and without symptomatic Alzheimer's disease
33. P1-349: A phase II double-blind, placebo-controlled randomized trial of an escalating dose of thalidomide in the treatment of Alzheimer's disease: Baseline characteristics
34. P1-249: KIF6 719Arg carrier status association with homocysteine and C-reactive protein in mild cognitive impairment and Alzheimer's disease
35. P2-223: Examination of body mass index, organ weights and diagnosed medical conditions in an autopsy series of nondemented individuals and individuals with Alzheimer's disease
36. P3-261: Concurrent validity of the Alzheimer's Questionnaire (AQ)
37. P2‐385: KIF6 719Arg allele predicts statin responsiveness in amnestic mild cognitive impairment and Alzheimer's disease patients
38. P4-024: How does diabetes affect plaque and tangle pathology in Alzheimer's Disease?
39. P4-435: A pilot phase IV open label study investigating the safety and tolerability of switching from the Exelon patch 9.5mg daily to Aricept 23mg daily in patients with moderate to severe AD
40. P2-064: Can the KIF6 polymorphism predict statin responsiveness in prodromal and symptomatic Alzheimer's disease?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.